The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis

Background. Immune checkpoint inhibitors (ICIs) have recently represented a breakthrough in urothelial carcinoma (UC). Proton pump inhibitors (PPIs) are routinely used for extended time periods in UC patients, with these agents having potentially and frequently undervalued effects on ICIs efficacy....

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Alessandro, Santoni, Matteo, Mollica, Veronica, Ricci, Angela Dalia, Calabrò, Concetta, Cusmai, Antonio, Gadaleta-Caldarola, Gennaro, Palmiotti, Gennaro, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145929/
https://www.ncbi.nlm.nih.gov/pubmed/35629263
http://dx.doi.org/10.3390/jpm12050842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145929/
https://www.ncbi.nlm.nih.gov/pubmed/35629263
http://dx.doi.org/10.3390/jpm12050842

Ejemplares similares